Skiplink Navigation

Main Features

Nestlé to buy Pfizer’s infant-nutrition business

Swiss food and drink giant Nestlé has announced a deal to acquire Pfizer’s infant-nutrition business for $11.85 billion (SFr10.8 billion).

The Vevey-based company says the acquisition, subject to regulatory approval, would “enhance its position in global infant nutrition”.

Nestlé CEO Paul Bulcke called the deal to buy the Pfizer nutrition unit “an excellent strategic fit”.

Nestlé said in a statement on Monday that estimated sales from the acquired business would be $2.4 billion in 2012.

It said 85 per cent of those sales are in emerging markets, many of which have large, fast-growing populations.

Nestlé is one of the world’s largest sellers of infant formula and may face some antitrust hurdles to complete the deal. and agencies


Neuer Inhalt

Horizontal Line

subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.

Click here to see more newsletters

swissinfo EN

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

Join us on Facebook!